Associated Papers
HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
Schrörs B et al.
Oncotarget, 2017
28423700 (PubMed )
Supplement: oncotarget-08-28312-s002.pdf
Select a paper to view details